CDC Guidelines for Management of Newborns Born to GBS‑Positive Mothers

1. Initial Assessment and Immediate Treatment

• Any newborn showing clinical signs of sepsis (e.g., respiratory distress, temperature instability, hemodynamic instability, altered consciousness) must receive a full diagnostic work‑up and empiric antibiotics irrespective of maternal GBS status or intrapartum antibiotic prophylaxis (IAP) adequacy. The work‑up includes blood culture, CBC with differential and platelets, chest radiograph if respiratory problems, and lumbar puncture if the infant is stable enough. Empiric therapy should consist of ampicillin (GBS coverage) plus gentamicin (gram‑negative coverage), adjusted for local resistance patterns. 1, 2

2. Maternal Chorioamnionitis Present

• When the mother receives intrapartum antibiotics for suspected chorioamnionitis, the newborn requires limited evaluation (blood culture at birth and CBC with differential/platelets at birth and/or at 6–12 h) and empiric ampicillin + gentamicin pending culture results, regardless of the infant’s clinical condition, duration of maternal antibiotics, or gestational age. 3, 2, 4, 1

3. Well‑Appearing Infants ≥ 37 Weeks Gestation – Adequate IAP

• For term infants whose mothers received ≥ 4 h of IV penicillin, ampicillin, or cefazolin before delivery and whose membranes ruptured < 18 h prior to birth, observation for ≥ 48 h is sufficient.
• Adequate prophylaxis is defined as ≥ 4 h of the specified IV beta‑lactam. 1
• If the infant is > 38 weeks, discharge criteria are met, reliable medical care is accessible, and a responsible caregiver is present, home observation may begin after 24 h; otherwise, the infant should remain hospitalized for at least 48 h. 3, 2

4. Well‑Appearing Infants ≥ 37 Weeks – Inadequate or No IAP

• When maternal IAP is < 4 h (or absent) but membranes ruptured < 18 h, observation for ≥ 48 h is recommended. 1

5. Well‑Appearing Infants < 37 Weeks or Prolonged Membrane Rupture

• Infants < 37 weeks gestation or with membrane rupture ≥ 18 h require a limited evaluation (blood culture at birth and CBC with differential/platelets at birth and/or 6–12 h) plus ≥ 48 h of hospital observation. 1

6. Duration Threshold for IAP

• The 4‑hour threshold remains the standard benchmark in CDC guidelines for defining adequate prophylaxis. 1

7. Special Considerations – Penicillin‑Allergic Mothers

• For mothers not at high risk for anaphylaxis, cefazolin administered ≥ 4 h before delivery is considered adequate prophylaxis. 3, 2
• For mothers at high risk for anaphylaxis who receive clindamycin or vancomycin, the effectiveness is uncertain and no specific duration threshold is supported by data. 1, 3

8. Critical Pitfalls to Avoid

• Duration of maternal antibiotics (≥ 4 h), not the number of doses, is the key metric linked to efficacy. Duration is more practical and more strongly associated with protection than dose count. 5

9. Development of Sepsis During Observation

• If any signs of sepsis appear while the infant is under observation, immediately perform a full diagnostic evaluation and start empiric antibiotics.
• Intrapartum prophylaxis does not alter the clinical spectrum of neonatal GBS disease nor delay onset among infants who develop infection despite prophylaxis.
• > 90 % of early‑onset GBS disease manifests within the first 24 h of life. 1, 3, 2

Management of Babies Born to GBS Positive Mothers

Maternal Intrapartum Antibiotic Prophylaxis

• The Centers for Disease Control and Prevention recommends intravenous penicillin G as the preferred agent for GBS-positive women without penicillin allergy, with a dosage of 5 million units initial dose, then 2.5-3.0 million units every 4 hours until delivery 6, 7
• For penicillin-allergic women not at high risk for anaphylaxis, cefazolin is recommended with a dosage of 2g IV initial dose, then 1g IV every 8 hours until delivery 6, 7
• For penicillin-allergic women at high risk for anaphylaxis, clindamycin is recommended if the GBS isolate is susceptible, otherwise vancomycin should be used 8, 9

Neonatal Management Algorithm

• The American Academy of Pediatrics recommends that any newborn with signs of sepsis requires a full diagnostic evaluation and immediate antibiotic therapy regardless of maternal GBS status or antibiotic prophylaxis 8, 9
• For well-appearing infants born to mothers with suspected chorioamnionitis, a limited evaluation and antibiotic therapy pending culture results is recommended 8, 9
• For well-appearing infants born to GBS-positive mothers who received adequate intrapartum antibiotic prophylaxis, routine clinical care is sufficient if born at ≥37 weeks gestation and if duration of membrane rupture was <18 hours 10
• The Centers for Disease Control and Prevention defines adequate intrapartum antibiotic prophylaxis as ≥4 hours of penicillin, ampicillin, or cefazolin before delivery 10

Important Clinical Considerations

• The American College of Obstetricians and Gynecologists recommends against the routine use of prophylactic antibiotics for all newborns born to mothers who received intrapartum prophylaxis 6, 7
• The duration of intrapartum antibiotics (≥4 hours) is more important than the number of doses for determining adequacy of prophylaxis 10

Pitfalls and Caveats

• The American College of Obstetricians and Gynecologists recommends not delaying medically necessary obstetric procedures to achieve 4 hours of GBS prophylaxis 8, 9
• Oral antibiotics should not be used to treat GBS colonization during pregnancy as this is ineffective in preventing neonatal disease 11, 12